Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TR-100

K-Number: K161551 · 2016-09-13

Decision Date2016-09-13
Product CodePBX
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

TR-100 is the device name listed in this FDA 510(k) record. The listed applicant is BTL Industries, Inc.. It received FDA 510(k) clearance on 2016-09-13 under 510(k) number K161551. The device is classified under product code PBX. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TR-100?

TR-100 is a medical device that received FDA 510(k) clearance on 2016-09-13. The listed applicant is BTL Industries, Inc.. The 510(k) number is K161551.

When did TR-100 receive FDA 510(k) clearance?

TR-100 received FDA 510(k) clearance on 2016-09-13, under 510(k) number K161551.

Who is the listed applicant for TR-100?

The FDA 510(k) record lists BTL Industries, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TR-100?

The FDA product code for TR-100 is PBX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing BTL Industries, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 34 devices →

Related Devices (Code: PBX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.